Yirmi Bir Akut Myeloid Lösemi Olgusunda İnterferon α-1b ve Interlökin-2 ile Birlikte Lenalidomid Tedavisi
Cheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong WeiAffiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Department of Hematology, Zhengzhou, ChinaAnahtar Kelimeler: Akut myeloid lösemi, Dirençli/nüks, Minimal kalıntı hastalık, Lenalidomid, İnterferon α, -1b, İnterlökin-2
Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia
Cheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong WeiAffiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Department of Hematology, Zhengzhou, ChinaKeywords: Acute myeloid leukemia, Refractory/relapsed, Minimal residual disease, Lenalidomide, Interferon α, -1b, Interleukin-2
Cheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong Wei. Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia. . 2021; 38(3): 230-232
Sorumlu Yazar: Xudong Wei, China
Sorumlu Yazar: Xudong Wei, China
| ARAÇLAR |
 Tam Metin PDF Yazdır Alıntıyı İndir RIS EndNote BibTex Medlars Procite Reference Manager E-Postala Paylaş Yazara e-posta gönder
Benzer makaleler Google Scholar |